Trust Company of Vermont’s BioTelemetry, Inc. BEAT Stock Holding History

Trust Company of Vermont’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-192	Closed	-$9K	–	808
2020 Q2	$9K	Hold	192	–	–	﹤0.01%	641
2020 Q1	$7K	Sell	192 -70	-27%	-$3.22K	﹤0.01%	721
2019 Q4	$12K	Hold	262	–	–	﹤0.01%	698
2019 Q3	$11K	Hold	262	–	–	﹤0.01%	741
2019 Q2	$13K	Hold	262	–	–	﹤0.01%	706
2019 Q1	$16K	Hold	262	–	–	﹤0.01%	648
2018 Q4	$16K	Hold	262	–	–	﹤0.01%	662
2018 Q3	$17K	Buy	+262	New	+$14.6K	﹤0.01%	722

Other funds holding BEAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Trust Company of Vermont's BEAT Position: Q3 2020 in Review

Trust Company of Vermont sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 192 shares — an estimated $9K sold.

Trust Company of Vermont first reported a position in BEAT in Q3 2018 and held it in 8 quarters. The position peaked at $17K in Q3 2018. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

Trust Company of Vermont reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
Trust Company of Vermont sold 192 BioTelemetry, Inc. shares in Q3 2020, an estimated $9K.
Trust Company of Vermont first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 8 quarters.
Trust Company of Vermont's BioTelemetry, Inc. position peaked at $17K in Q3 2018.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Trust Company of Vermont's 13F filing for Q3 2020, filed 6 Nov 2020.